BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31894518)

  • 21. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
    Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
    J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Press RH; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Burri SH; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):632-638. PubMed ID: 28581405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
    Lester-Coll NH; Dosoretz AP; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery.
    Shenker RF; McTyre ER; Taksler GB; D'Agostino RB; Cramer CK; Ruiz J; Alphonse-Sullivan NK; Farris M; Watabe K; Xing F; Laxton AW; Tatter SB; Chan MD
    Clin Neurol Neurosurg; 2019 Jan; 176():10-14. PubMed ID: 30468997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).
    Sperduto PW; Shanley R; Luo X; Andrews D; Werner-Wasik M; Valicenti R; Bahary JP; Souhami L; Won M; Mehta M
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):526-31. PubMed ID: 25304947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Gorovets D; Ayala-Peacock D; Tybor DJ; Rava P; Ebner D; Cielo D; Norén G; Wazer DE; Chan M; Hepel JT
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):246-253. PubMed ID: 28068233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety-net versus private hospital setting for brain metastasis patients treated with radiosurgery alone: Disparities in follow-up care and outcomes.
    Diao K; Sun Y; Yoo SK; Yu C; Ye JC; Trakul N; Jennelle RL; Kim PE; Zada G; Gruen JP; Chang EL
    Cancer; 2018 Jan; 124(1):167-175. PubMed ID: 28902402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy.
    Hsu F; Kouhestani P; Nguyen S; Cheung A; McKenzie M; Ma R; Toyota B; Nichol A
    Radiother Oncol; 2013 Jul; 108(1):128-31. PubMed ID: 23742960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage Stereotactic Radiosurgery in Breast Cancer Patients with Multiple Brain Metastases.
    Perez JL; Ozpinar A; Kano H; Phan B; Niranjan A; Lunsford LD
    World Neurosurg; 2019 May; 125():e479-e486. PubMed ID: 30710716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
    Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
    Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy.
    McTyre ER; Johnson AG; Ruiz J; Isom S; Lucas JT; Hinson WH; Watabe K; Laxton AW; Tatter SB; Chan MD
    Neuro Oncol; 2017 Apr; 19(4):558-566. PubMed ID: 27571883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006121. PubMed ID: 20556764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.